SCHEMBL7318571

SCHEMBL7318571

C[C@H](N)C(=O)Oc1ccc(Cl)c(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
KMO O15229 1/20 0.41
CHRNA3 P32297 1/20 0.40
HSP90AA1 P07900 1/20 0.40
ELANE P08246 1/20 0.40
PNMT P11086 1/20 0.40
SLC6A3 Q01959 2/20 0.39
FFAR1 O14842 1/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39
CYP3A4 P08684 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11068943 1.00 PPARG (0.41) PPARGPPARAKDM4EALDH1A1LMNA
SCHEMBL27486346 0.87 NR1H4 (0.41) ALDH1A1LMNAHSP90AA1ELANEGRIN2D
SCHEMBL7001546 0.86 ELANE (0.55) PPARGPPARAKDM4EALDH1A1LMNA
SCHEMBL11239814 0.85 MAPT (0.43) KDM4ELMNAGRIN2DGRIN3BGRIN1
SCHEMBL27497673 0.84 TAS1R3 (0.47) ALDH1A1LMNACYP2D6
SCHEMBL23493150 0.81 ELANE (0.55) ALDH1A1LMNAELANEGRIN2DGRIN3B
SCHEMBL15679080 0.81 ELANE (0.55) ALDH1A1LMNAELANEGRIN2DGRIN3B
SCHEMBL8895329 0.81 TTR (0.38) ALDH1A1LMNAELANEGRIN2DGRIN3B
SCHEMBL6509969 0.80 GRIN2D (0.53) PPARALMNAELANEGRIN2DGRIN3B
SCHEMBL2941688 0.80 GRIN2D (0.53) PPARALMNAELANEGRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110506049-A For combining the peptide ligand of MT1-MMP BICYCLETX LTD 2019-11-26 CN claimed
EP-0961779-A1 SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS SYNPHAR LABORATORIES INC. (CA) 1999-12-08 EP claimed
WO-1998032766-A1 SUBSTITUTED AMINO BICYCLIC-β-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS SYNPHAR LABORATORIES INC. (US) 1998-07-30 WO claimed
CN-110506049-A For combining the peptide ligand of MT1-MMP BICYCLETX LTD 2019-11-26 CN disclosed
CN-106946748-B Deliver method, compound, composition and the carrier of 3-APS BHI有限合资公司 2019-02-05 CN disclosed
CN-104379146-B Inhibit the composition and method of varial polymerases 拜奥克里斯特制药公司 2018-07-10 CN disclosed
CN-104284891-B Conformationally constrained, fully synthetic macrocyclic compounds 波利弗尔股份公司 2018-04-17 CN disclosed
CN-105007928-B For treating the synthesizing linear APELIN analogies of heart failure 诺华股份有限公司 2018-03-20 CN disclosed
CN-106946748-A Deliver method, compound, composition and the carrier of the propane sulfonic acid of 3 amino 1 BHI有限合资公司 2017-07-14 CN disclosed
CN-106573073-A FAP-activated therapeutics and uses related thereto 塔夫茨大学信托人 2017-04-19 CN disclosed
CN-103787927-B Deliver method, compound, compositionss and the carrier of 3 amino 1 propane sulfonic acid BHI有限合资公司 2017-03-01 CN disclosed
CN-104379146-A Compositions and methods for inhibiting viral polymerase BIOCRYST PHARM INC 2015-02-25 CN disclosed
CN-1599577-A Peptide-based multimeric targeted contrast media EPIX MEDICAL INC (US) 2005-03-23 CN disclosed
US-6232305-B1 ANTICANCER AGENTS; BONE DISORDERS; ANTIARTHRITIC AGENTS; RESPIRATORY SYSTEM DISORDERS NAEJA PHARMACEUTICAL INC. (CA) 2001-05-15 US disclosed
EP-0961779-A1 SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS SYNPHAR LABORATORIES INC. (CA) 1999-12-08 EP disclosed
WO-1998032766-A1 SUBSTITUTED AMINO BICYCLIC-β-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS SYNPHAR LABORATORIES INC. (US) 1998-07-30 WO disclosed